CELESTE MULLINS: Open Payments
NPI 1922437011 · BIG STONE GAP, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,444 in 53 payments from 12 companies in 2025. Trend: 2023 $38,324 · 2024 $12,291 · 2025 $2,444
Food & beverage: $1,319Speaker / faculty: $1,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $1,228 |
| Alkermes, Inc. | 2 | $247 |
| Vanda Pharmaceuticals Inc. | 4 | $200 |
| E.R. Squibb & Sons, L.L.C. | 4 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $148 |
| Axsome Therapeutics, Inc. | 3 | $147 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
Products named: FANAPT, COBENFY, CAPLYTA, Auvelity, AIRSUPRA, LYBALVI, ARISTADA, VRAYLAR.
Industry payments across VA — which companies pay providers there.
